G6PD activation is a first-line response against oxidative stress in cancer cells, and is thought in association with immune escape, tumor progression, and chemotherapy resistance in many cancers [156], which is contradicts Ding Lei's findings. The gene discussed is G6PD; the disease is neoplasm.